Executive Summary
- biomarkers
- 816,003 biomarker rows across 11,427 reports, 12-month window ending Dec 2025
- claims
- 74,339 hospital claims, ₹320.6 Cr incurred, 12-month window ending Dec 2025
- survey
- 9,097 respondents, ~126 questions, fielded Mar–Apr 2026
Key takeaways
- Workforce health risk is now visible three ways at once. WHI 2026 reads the same broad audience through blood panels, a behaviour survey, and hospital claims — and the metabolic risk the 2025 report flagged shows up in all three layers. The health problem is now legible as a business cost.
- 38.7% of tested professionals show glucose dysfunction — and only 5.8% know it. The biomarker rate held against 37.2% in WHI 2025 on a sample four times the size, and runs roughly 7× ahead of self-reported diagnosis. Most metabolic risk in the Indian workforce is invisible to the person carrying it.
- The dependent layer is sicker and more expensive than the employee. Spouses, children, and parents file 66.5% of claims and ₹217.4 Cr of incurred cost — more than twice the employee's ₹103.1 Cr. The parent layer alone, at ₹118.2 Cr, is the single largest block in the policy.
- Screening is gated by income, not by need. Full-body diagnostic testing runs from 15.6% among the lowest earners to 54.3% among the highest — a 3.5× gap that holds inside a single job function and a single employer plan, where the cover is identical.
- AI has passed Google as a health-information source. AI tools now rank second behind the doctor at 19.8%, narrowly ahead of search at 19.7%. Among workers in their 20s, one in five reaches for the internet, AI, or an influencer without naming a clinician at all.
- Stress and sleep moved the wrong way; the protective markers barely moved at all. High stress rose to 40.4% (from 33.9%) and short sleep to 30.7% (from 27.3%). Vitamin D insufficiency sits at 81.4% and B12 deficiency at 69.6% — near-universal, and statistically unchanged.
WHI 2025 established the health problem: urban working Indians are entering chronic-disease pathways early, with glucose dysfunction, weak cardiovascular protection, liver strain, anemia, and micronutrient deficits showing up during peak career years. WHI 2026 makes the business problem visible. The same risk now appears in three parallel evidence layers — what people report doing, what their blood reveals, and what their employers pay for — and the three converge on the same story.
The three datasets are large. Blood panels from 11,427 annual checkups. A behaviour survey of 9,097 respondents across 126 questions. And 74,339 hospital claims carrying ₹320.6 crore of incurred cost across a 12-month window. No other organisation in India can assemble these three views of the same workforce universe. They are not linked at the individual level — the report reads them as audience-level patterns, never as person-by-person chains — but read together, the convergence is hard to dismiss as coincidence.
The clinical risk held its ground on a much larger sample#
The headline metabolic findings from WHI 2025 did not fade. On a biomarker base four times larger, the rates barely moved.
| Marker | WHI 2025 | WHI 2026 | Read |
|---|---|---|---|
| Glucose dysfunction (HbA1c ≥5.7%) | 37.2% | 38.7% | Held |
| Low HDL (strict <40 mg/dL) | 47.7% | 44.0% | Slightly lower |
| Female anemia (Hb <12 g/dL) | 37.1% | 34.6% | Still severe |
| Vitamin D insufficient (<30 ng/mL) | 84.0% | 81.4% | Near-universal |
| Vitamin B12 low (<300 pg/mL) | 68.2% | 69.6% | Held |
The clinical risk held its ground on a much larger sample
Five biomarker headlines, WHI 2025 vs WHI 2026 — the bars sit almost level
Y-axis from zero — no marker moved more than ~3.7 points across a four-fold sample increase. Stability, not movement.
The persistence is the finding. A rate that holds across a sample four times larger is not a sampling artefact. The metabolic curve in the Indian workforce is not bending. Glucose dysfunction doubles between the 20s and the 30s — from 16.7% to 33.0% — then climbs to 69.1% by the 50s, and it is the one marker that worsens monotonically with every decade of working life. The protective and micronutrient signals are even more stubborn: four in five professionals carry insufficient vitamin D, and two-thirds carry low B12, in numbers that have not moved in a year of measurement.
The behaviour layer is moving the wrong way#
The survey explains why the clinical picture isn't improving. The behaviours that feed metabolic risk worsened year on year, and the protective ones didn't fill the gap.
| Behaviour | WHI 2025 | WHI 2026 | Read |
|---|---|---|---|
| High stress last week (7–10/10) | 33.9% | 40.4% | Higher |
| Sleep under 6 hours | 27.3% | 30.7% | Higher |
| Zero 30-minute exercise days | 28.0% | 30.9% | Higher |
| Takes no supplement | — | 66.2% | — |
| Took no preventive action last year | — | 42.3% | — |
The behaviour layer is moving the wrong way
The three comparable behaviour readings, WHI 2025 → WHI 2026 — all three rose
Higher is worse on all three rows. Movement, sleep, and stress each deteriorated year on year.
Stress, short sleep, and inactivity all rose. The survey's strongest internal signal is that these behaviours cluster: high-stress respondents are 1.73× as likely to be short sleepers, and short sleep climbs cleanly with caffeine intake. Against the workaholic stereotype, IT and SaaS is the best-sleeping major industry, and hybrid — not fully remote — is the healthiest work mode on every behaviour measured. Working from home reports the highest stress of the three modes. Removing the commute did not remove the strain.
The behaviour data also carries the report's clearest equity finding. Preventive screening does not track risk; it tracks income. Full-body diagnostic testing runs at 15.6% among the lowest earners and 54.3% among the highest, a gap that survives even when job function and age are held constant. The people the cover is designed to catch early are the ones least likely to use it.
The cost layer shows where the risk is already being paid for#
Claims are the proof layer WHI 2025 didn't have. Loop's broker book absorbed ₹320.6 crore of hospital cost across 74,339 claims in the latest twelve months — the economic shadow of the workforce health problem the first two layers describe.
Two structural facts run through the cost data. The first is that frequency and cost are different documents. Infection, fever, and general health services fill the claim queue; musculoskeletal injury, cardiac admissions, and cancer move the money. The costliest 10% of claims account for nearly half of all spend. The second, and larger, is who the policy actually pays for.
| Layer | Share of claims | Share of incurred | Total incurred |
|---|---|---|---|
| Employee | 33.5% | 32.2% | ₹103.1 Cr |
| Spouse | 22.7% | 21.5% | ₹68.9 Cr |
| Child | 14.3% | 9.4% | ₹30.3 Cr |
| Parent / parent-in-law | 29.4% | 36.9% | ₹118.2 Cr |
The rupee bar and the count bar are different shapes
Share of claims vs share of incurred cost, by relationship to the policy
Share of claims
Share of incurred
The parent / parent-in-law layer is 29.4% of claims but 36.9% of incurred (₹118.2 Cr) — the largest block of the rupee bar.
The employee is a minority customer of their own health policy. Two-thirds of claims, and more than two-thirds of cost, sit in the family system, with the parent layer the single largest payer group — larger than the employee's own. The bigger the employer, the heavier this layer runs: at Enterprise tier, parents and parents-in-law drive 42.7% of the entire incurred bill, against 18.8% at SME tier. A large-company health policy is, more than anything else, a financing instrument for its workforce's elders.
The navigation layer is shifting under everyone's feet#
How people find health information is changing faster than any clinical marker. The doctor is still the first stop — 54.0% name a clinician, and no other source clears 25%. But the second-ranked source is now AI, at 19.8%, narrowly ahead of Google search at 19.7%. A category that did not exist in clinics three years ago has passed the search engine that defined two decades of self-diagnosis. AI use collapses with age and rises with income, and among workers in their 20s, more than one in five names no clinician at all — relying instead on the internet, AI, or an influencer.
The employer-funded channel is the one that's losing. Workplace wellness programs reach 8.0% as a health-information source, the lowest-ranked channel on the list. Employers fund the benefit, then lose the information layer to a chatbot.
How to read the rest of this report#
The sections that follow move from signal to cost to action. Risk Signals reads the eight biomarker systems — blood sugar, lipids, anemia, vitamin D and B12, liver, inflammation, kidney. Lifestyle Drivers reads the eleven behaviour layers behind them, from sleep and stress to caffeine, alcohol, and GLP-1 awareness. Workforce Segments cuts the data by gender, age, work model, income, and the self-versus-dependent split. Cost Signals — the major new section for 2026 — reads the claims book: who claims, what costs, where the friction lives. Cities maps the metros, and the Employer Action Playbook turns the findings into plan-design moves. Each page leads with its own takeaways and carries its own data.
References
- 1Anjana, R. M., Unnikrishnan, R., Deepa, M., et al. (2023). Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study. The Lancet Diabetes & Endocrinology, 11(7), 474–489. https://doi.org/10.1016/S2213-8587(23)00119-5
- 2Pradeepa, R., & Mohan, V. (2021). Epidemiology of type 2 diabetes in India. Indian Journal of Ophthalmology, 69(11), 2932–2938. https://doi.org/10.4103/ijo.IJO_1627_21
- 3GBD 2021 Anaemia Collaborators. (2023). Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021. The Lancet Haematology, 10(9), e713–e734. https://doi.org/10.1016/S2352-3026(23)00160-6
- 4G, R., & Gupta, A. (2014). Vitamin D deficiency in India: prevalence, causalities and interventions. Nutrients, 6(2), 729–775. https://doi.org/10.3390/nu6020729